| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |